rxstat › Shortages › Mometasone Furoate

Mometasone Furoate (Elocom, Asmanex Twisthaler) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 29, 2026

Also sold as: Elocom, Asmanex Twisthaler, Nasonex, Mosaspray

Some Mometasone Furoate products are in shortage in Canada (3 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Apr 27, 2027.

A corticosteroid used to treat nasal allergies, asthma and inflammatory skin conditions.

Products affected
3 / 15
In shortage since
Feb 12, 2025
Est. full return
Apr 27, 2027
Reports on file
116
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · since Aug 26, 2026, est. end Apr 27, 2027 · Shortage of an active ingredient.
Active shortage
APO-MOMETASONE
50MCG · SPRAY, METERED DOSE · APOTEX INC
DIN 02403587 · since Apr 21, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-MOMETASONE
50MCG · SPRAY, METERED DOSE · TEVA CANADA LIMITED
DIN 02475863 · since Feb 12, 2025, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596
Resolved
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · ended Sep 25, 2026 · Shortage of an active ingredient.
Resolved
ASMANEX TWISTHALER
200MCG · POWDER · ORGANON CANADA INC.
DIN 02243595 · ended Sep 25, 2026 · Shortage of an active ingredient.
Resolved
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · ended Sep 25, 2026 · Shortage of an active ingredient.
To be discontinued
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690
To be discontinued
ASMANEX TWISTHALER
200MCG · POWDER · ORGANON CANADA INC.
DIN 02243595
To be discontinued
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596
Resolved
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · ended Aug 7, 2026 · Delay in shipping of the drug.
To be discontinued
ELOCOM
0.1% · LOTION · ORGANON CANADA INC.
DIN 00871095

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Mometasone Furoate is currently affected by 3 active shortage reports filed with Health Canada by ORGANON CANADA INC., APOTEX INC, TEVA CANADA LIMITED.

The reported causes are: shortage of an active ingredient; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Mometasone Furoate is classified under “OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS” (ATC R03BA).

Recent changes

Common questions

What is Mometasone Furoate used for?

A corticosteroid used to treat nasal allergies, asthma and inflammatory skin conditions.

When will Mometasone Furoate be back in stock in Canada?

The latest manufacturer estimate is Apr 27, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Mometasone Furoate in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other drugs for obstructive airway diseases, inhalants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Fluticasone Furoate (Avamys) No current shortage Budesonide (Pulmicort Turbuhaler) Partial shortage 3 of 17 reported products affected Fluticasone Propionate (Flovent Hfa) Partial shortage 1 of 15 reported products affected Tiotropium (Spiriva) Partial shortage 1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.